pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3194 |
Genomic Coordinates | chr20: 51452905 - 51452977 |
Description | Homo sapiens miR-3194 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||
---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3194-5p | ||||||
Sequence | 10| GGCCAGCCACCAGGAGGGCUG |30 | ||||||
Evidence | Experimental | ||||||
Experiments | Illumina | ||||||
SNPs in miRNA |
|
||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ATCAY | ||||||||||||||||||||
Synonyms | BNIP-H, CLAC | ||||||||||||||||||||
Description | ATCAY, caytaxin | ||||||||||||||||||||
Transcript | NM_033064 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ATCAY | |||||||||||||||||||||
3'UTR of ATCAY (miRNA target sites are highlighted) |
>ATCAY|NM_033064|3'UTR 1 GGCGACGTGAGCATAACAAAGGACATGGAAGAAGATTCCAGATGCCAGAAAACCTCTGTCAGACGCCCACTGGCCCCAGA 81 TCTCATCCTGCCTCATCCTGAGTCCCAATCTTCCAAGGGTGCCAGCCCCTCCGTTCATCTCTGAAACCCAGCATCCTTTT 161 CAGCTGCTTGAAAACATTGTATTTTTTTTTTTTAACGATGCAGTATTTGTGCGTTCCAGAAAAGGGCCCAGCTCTGAGCC 241 CCTCACCCTTCCACACTCACGAACTCTCAGCCGAGGAAGGCAAGAAGCGCAGGGGGTGGCCCGCGTGGCGTCGGTGGCCT 321 CCGCTCCTGCTCGCAGCCCCTGTGGTCAGAGCTGGATACAAGATTCAAGACCCTTCTCTTGCTTGTCACCCGCTCCAGGT 401 TGGAGCCACAGACACCCACCGCCACCCCGGCTGGGTCTGCGTCCTTTCCTGTGCCTTTCCCTCCAGAATGCGGCCTCAGA 481 CCTAGAAGCTCAACCCCCCTATGAGGGCCACGTCCTGGGGTAGCTCCTGACCTCCGACCTTATGTCCAAATTTCACACCC 561 ATGGTTTTTCATTTGACCCGCCCCCTTCTCGCTCATAATGACACCCAGCTCCTTTGAGAGGATCAGAGCCCATTGCACAA 641 GAAGAGCCGCTGCCAACCATCCTTGTCCTCCGATTGCAAAATGACACCCCAGTAATCTAGAACATTCTCAAGCCCCTTTA 721 ACTCAGATGTCAAGCCACCGGGCAAACCCCGTCAATACCTCCCACCAAGGAATGAGATATGTGGACCTCACTGCTCCCCC 801 AACCCAGCGTCAGGCTGGGACACGCCAACGCTGTTCCGGGTTGGAACAGCAGAGGCTCAGAAACTGGCTCTGAAATAGGC 881 AGACCTAGCAAGAGGAAGATACAGGGTATCGGGCGTTTGAGTGTTTCAGAAGTCATTCGGGAAGATAAATCCAGTGCGCT 961 GGCCGCAGCCACCTGCATTCAAAGCTTGGACCAGCGGGTTCTTGTTCGGGAGGCAAATTTCCCTAGGAAAAAGAAGACAG 1041 ACTTTTCTAATGTGGTCCAAATGCGGATCACTGGTCAGATGGACTCTAGAAGCACTGAGCTCCCTGTCTCTGGAAGTATT 1121 TAAGAAAAGGCTGGGCCAGGCACGATGGCTCACGCCTGTAATCCCAGACTTTGGGAGGCCGAGGCAGGCGGATCACCTGA 1201 GGTGAGGAGTTTGAGAACAGCCTGGCCAACATGGTGAAACCTCATCTCTACTAAAAATACAAAAATTAGCCAGGCGTGGT 1281 GGCAGGTGCCTGTAATCCCAGCTACTTGGGAGGCTGAGGCATGAGAATCACTTAAACCTGAGAGGCAGAGGTTACAGTGA 1361 GCCAAGATCGTGCCACTGCATTCCAGCCTGGGCGACAGAGCAAGACTCTGTCTCAAAAAAAATAAAAAATAATCAGGGCA 1441 CAGTGGCTCATGCCTGTAATCCCAGCACTCTGGGAGGCTGAGGTGGGTGGATCACCTGAGGTCAGGAGTTCAAGACCAGC 1521 CTGGTGAACATGGCGAAACCCCGTCTCTAATAAAAATACAAAAATTAGCCGGGCATGGTGGTGCATGCCTGTAATCCCAG 1601 CTACTCGGGAGGCTGAGGCAGGAGAACTGCTTGAACCCAGGAGGCAGAGGTTGCAGTGATCCAAGATCATGCCACTGCAC 1681 TCCAGCCTGGGCAACAAGAGCAAAACTCCGTCTCAAAATAAAAAGAAAAGAAAAGAATGGACAGTGTTTGCAGAGAGTTG 1761 CTCACGAGTTTCCCTCTAATCCTAAATGTCTTCATGTCTATCAGTCTGAGCAGACGGTGAGTAGGGCGGGCACATTCTCC 1841 AGGCCCTTCTTCCTAGCTCTGTGGTTGACCTCTCAGCAAGTGCTATCCAGGCTGGGCCAACCAGACCCACAATTAACTGA 1921 GCCTCAGTGAAAGCGTCCAGTGCATCTTGACCTGAGACAGCAAGGAATTGCATTTGGGGTTATTCCAACGATGATGGCAG 2001 GGAACTGGTGGTATTTAGTGCTGAGGGGCAGTGATACAGAAAGATTTGCCCTGTGGGACAGGGTCCTGCGCGAGTCCCAT 2081 CCCCAAAAGCCAGCAGCTCCTGCCATGAGGAAGACGGGGTTTCTGAGCAGGCTTATGCCTGCAGGTTCCTGTGGAGCCAC 2161 CGGCTGTGACGGGACACCTCTGGGTCTCAGCATTGCCCTGGGGAGGCTGGGACATTTAGGGACATGGTAGGGTTTTAACA 2241 TTTGTTTCCCAAATGTCAAATCCCGGGCACAGGGGCAAGACCCTGTCCCGAATTCCCACCCCAGTGAATGGTGTCGCTGC 2321 CAAAGCCAACACAAGATGACAAAAGTGGCTGGGTACGGTGGCTCACGCCTATAATCCCAGCACTTTGGGAGACCGAGACA 2401 GGTGGATCACCTGAGGTCAGGAGTTCGAGACCAGGCTGGCCAACATGGTGAAACCCCATCTCTACTAAAAATACAAAAAT 2481 TAGCTGGGTGTGGTGGCGCGCACCTGTAGTCCCAGCTACTCAGGAGGCTGAGGTAGAAGAATAGCTGGAACCCAGGAGGC 2561 AGAGATTGCAGTCAGCCGAGATTGCACCACTGCACTCCAGCCTGGGAGACAGAGCAAGACTGACTCAAAAGAAAAAAAAT 2641 GACAGAAGCCTGATTATCAGACTGCCCGGAGGAGACAGGCTCCAGCAGATAGATGCCAGCCAGGCCCAGCTGCCACGATT 2721 TGTCCCAGGTGACCAAAGGCACGCAGCTCCAGCATGAATCGTTCTAACCCAACAGTGACAAGAACTGCTGGGCCTTAACC 2801 GTCATGGAAGACTGGGGCCGCTTCCAAGTCACAGACAGGAGACGGGGACAGGAAAGAACTCATTCCACCCAATCGGACAC 2881 CTAATAATTGAGTGTCTACAGCAGCAATCAAGTGACAAGTGAGGCCCTACCTGACCCAGAAGGTGCCTGCCGGCTAAACA 2961 TTCTGCCCCCACCAGAAACTCCAGGGGGTCCGCCCGTTATGCCGTGGCCCACCCACGCCCCTTTGGATCACCAGCAGTCA 3041 CAGACAACAGGCAGGCGAAACTGAAGACCCCAACTCAGCCCCAGCGGACCCTCCAGAGCAAAAGAGGCCCCCGGCGAGGC 3121 CACCTGTCGGCAGGCATGCCGAGGTCAAACAGCCGGGGCCACCGTTCCCAGCTGGGCCACGACCTGCACCGTCCACAGAT 3201 GGGCTTTGAGATGGATTTGTATCAGGGTGGGGGGTGTGGTTTGGCCAAAATGCAATGGACCCCGACCCCTCCTCGTAAAA 3281 GGATGTTGGGTTTCCCTCTGGTGACACATGGGATGCGTCATAAACCCTCCCCCAAAGTCCTGGTCAGCAGCCCATCCTTC 3361 CAACGATGAGTTTTGCGGTTTTTCAGAACAGAAATGATCACTACGATTGACGACGGTCGTGATGTTAAGACGTCGTCTCC 3441 ATGAGCTTTGGGGGGACTTTTATGTGGAATAAAGAAACTATCACTGAGAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 85300.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065668. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293S |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084041. RNA binding protein: AGO2. Condition:CLIP_arsenite_rep1
HITS-CLIP data was present in GSM1084044. RNA binding protein: AGO2. Condition:CLIP_noarsenite_rep3
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
CLIP-seq Support 1 for dataset GSM4903829 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Human neurons / CTLTD_shCTL_a |
Location of target site | NM_033064 | 3UTR | GCCAACAUGGUGAAACCCCAUCUCUACUAAAAAUACAAAAAUUAGCUGGGUGUGGUGGCGCGCACCUGUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161238 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903831 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Human neurons / 124TD_shELAVL3_a |
Location of target site | NM_033064 | 3UTR | GGCCAACAUGGUGAAACCCCAUCUCUACUAAAAAUACAAAAAUUAGCUGGGUGUGGUGGCGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161238 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_033064 | 3UTR | GCUGGCCAACAUGGUGAAACCCCAUCUCUACUAAAAAUACAAAAAUUAGCUGGGUGUGGUGGCGCGCACCUGUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_033064 | 3UTR | CUGGCCAACAUGGUGAAACCCCAUCUCUACUAAAAAUACAAAAAUUAGCUGGGUGUGGUGGCGCGCACCUGUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_033064 | 3UTR | GCUGGCCAACAUGGUGAAACCCCAUCUCUACUAAAAAUACAAAAAUUAGCUGGGUGUGGUGGCGCGCACCUGUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_033064 | 3UTR | GCUGGCCAACAUGGUGAAACCCCAUCUCUACUAAAAAUACAAAAAUUAGCUGGGUGUGGUGGCGCGCACCUGUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_033064 | 3UTR | GCUGGCCAACAUGGUGAAACCCCAUCUCUACUAAAAAUACAAAAAUUAGCUGGGUGUGGUGGCGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_033064 | 3UTR | GCUGGCCAACAUGGUGAAACCCCAUCUCUACUAAAAAUACAAAAAUUAGCUGGGUGUGGUGGCGCGCACCUGUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM1084041 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_arsenite_rep1 |
Location of target site | ENST00000450849.2 | 3UTR | GUGGAUCACCUGAGGUCAGGAGUUCGAGACCAGGCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 10 for dataset GSM1084044 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_noarsenite_rep3 |
Location of target site | ENST00000450849.2 | 3UTR | ACAGGUGGAUCACCUGAGGUCAGGAGUUCGAGACCAGGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 11 for dataset GSM1065668 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_7 |
Location of target site | ENST00000450849.2 | 3UTR | GUUCGAGACCAGGCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
72 hsa-miR-3194-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT443250 | C9orf170 | chromosome 9 open reading frame 170 | 2 | 2 | ||||||||
MIRT443284 | ZC3H12A | zinc finger CCCH-type containing 12A | 2 | 2 | ||||||||
MIRT461518 | EMC7 | ER membrane protein complex subunit 7 | 2 | 2 | ||||||||
MIRT466738 | SYNJ2BP | synaptojanin 2 binding protein | 2 | 2 | ||||||||
MIRT467651 | SLC7A1 | solute carrier family 7 member 1 | 2 | 2 | ||||||||
MIRT472998 | MRPS23 | mitochondrial ribosomal protein S23 | 2 | 4 | ||||||||
MIRT477911 | DUSP2 | dual specificity phosphatase 2 | 2 | 2 | ||||||||
MIRT480853 | BLCAP | bladder cancer associated protein | 2 | 2 | ||||||||
MIRT482890 | IAH1 | isoamyl acetate-hydrolyzing esterase 1 homolog | 2 | 4 | ||||||||
MIRT487295 | SLC38A9 | solute carrier family 38 member 9 | 2 | 2 | ||||||||
MIRT488494 | SFMBT2 | Scm like with four mbt domains 2 | 2 | 4 | ||||||||
MIRT489060 | STARD3 | StAR related lipid transfer domain containing 3 | 2 | 2 | ||||||||
MIRT491209 | MLLT1 | MLLT1, super elongation complex subunit | 2 | 4 | ||||||||
MIRT491479 | APC2 | APC2, WNT signaling pathway regulator | 2 | 8 | ||||||||
MIRT492558 | PRX | periaxin | 2 | 6 | ||||||||
MIRT495499 | SLC39A2 | solute carrier family 39 member 2 | 2 | 2 | ||||||||
MIRT496578 | ZNF280D | zinc finger protein 280D | 2 | 2 | ||||||||
MIRT496840 | KCNIP2 | potassium voltage-gated channel interacting protein 2 | 2 | 2 | ||||||||
MIRT497840 | CHD1 | chromodomain helicase DNA binding protein 1 | 2 | 2 | ||||||||
MIRT499396 | PLCG2 | phospholipase C gamma 2 | 2 | 7 | ||||||||
MIRT503237 | C16orf74 | chromosome 16 open reading frame 74 | 2 | 4 | ||||||||
MIRT512345 | ZNF665 | zinc finger protein 665 | 2 | 4 | ||||||||
MIRT512527 | ATCAY | ATCAY, caytaxin | 2 | 4 | ||||||||
MIRT513160 | PPIB | peptidylprolyl isomerase B | 2 | 2 | ||||||||
MIRT514493 | STOML1 | stomatin like 1 | 2 | 2 | ||||||||
MIRT517164 | SLC28A1 | solute carrier family 28 member 1 | 2 | 2 | ||||||||
MIRT520463 | TRPV2 | transient receptor potential cation channel subfamily V member 2 | 2 | 2 | ||||||||
MIRT524151 | DIP2A | disco interacting protein 2 homolog A | 2 | 2 | ||||||||
MIRT530324 | TNFRSF10D | TNF receptor superfamily member 10d | 2 | 2 | ||||||||
MIRT533747 | TMEM184B | transmembrane protein 184B | 2 | 2 | ||||||||
MIRT534259 | SLC12A7 | solute carrier family 12 member 7 | 2 | 2 | ||||||||
MIRT561273 | ZDHHC18 | zinc finger DHHC-type containing 18 | 2 | 2 | ||||||||
MIRT569126 | TMC5 | transmembrane channel like 5 | 2 | 4 | ||||||||
MIRT569937 | RAB8A | RAB8A, member RAS oncogene family | 2 | 2 | ||||||||
MIRT570073 | VPS8 | VPS8, CORVET complex subunit | 2 | 2 | ||||||||
MIRT570636 | KLF13 | Kruppel like factor 13 | 2 | 2 | ||||||||
MIRT571026 | CENPP | centromere protein P | 2 | 2 | ||||||||
MIRT573838 | ZWINT | ZW10 interacting kinetochore protein | 2 | 2 | ||||||||
MIRT574899 | Plcg2 | phospholipase C, gamma 2 | 2 | 5 | ||||||||
MIRT576070 | Poteg | POTE ankyrin domain family, member G | 2 | 2 | ||||||||
MIRT576753 | Tmem127 | transmembrane protein 127 | 2 | 2 | ||||||||
MIRT611795 | WNT9A | Wnt family member 9A | 2 | 2 | ||||||||
MIRT616756 | SVOP | SV2 related protein | 2 | 2 | ||||||||
MIRT630965 | NGDN | neuroguidin | 2 | 2 | ||||||||
MIRT634555 | LYVE1 | lymphatic vessel endothelial hyaluronan receptor 1 | 2 | 2 | ||||||||
MIRT638646 | GK5 | glycerol kinase 5 (putative) | 2 | 2 | ||||||||
MIRT639903 | SRGAP2 | SLIT-ROBO Rho GTPase activating protein 2 | 2 | 2 | ||||||||
MIRT640529 | TET3 | tet methylcytosine dioxygenase 3 | 2 | 4 | ||||||||
MIRT644529 | TMEM134 | transmembrane protein 134 | 2 | 2 | ||||||||
MIRT644887 | C2orf50 | chromosome 2 open reading frame 50 | 2 | 2 | ||||||||
MIRT647729 | CXCR2 | C-X-C motif chemokine receptor 2 | 2 | 2 | ||||||||
MIRT648086 | FAM192A | family with sequence similarity 192 member A | 2 | 2 | ||||||||
MIRT650808 | PGRMC1 | progesterone receptor membrane component 1 | 2 | 2 | ||||||||
MIRT660505 | ARPC2 | actin related protein 2/3 complex subunit 2 | 2 | 2 | ||||||||
MIRT667193 | NODAL | nodal growth differentiation factor | 2 | 2 | ||||||||
MIRT685675 | PSMB7 | proteasome subunit beta 7 | 2 | 2 | ||||||||
MIRT692710 | MEAF6 | MYST/Esa1 associated factor 6 | 2 | 2 | ||||||||
MIRT693598 | SLC39A1 | solute carrier family 39 member 1 | 2 | 2 | ||||||||
MIRT698059 | TRIOBP | TRIO and F-actin binding protein | 2 | 2 | ||||||||
MIRT698292 | TMEM2 | transmembrane protein 2 | 2 | 2 | ||||||||
MIRT702353 | KLHL26 | kelch like family member 26 | 2 | 2 | ||||||||
MIRT708623 | NUDT18 | nudix hydrolase 18 | 2 | 2 | ||||||||
MIRT714289 | KBTBD11 | kelch repeat and BTB domain containing 11 | 2 | 2 | ||||||||
MIRT714577 | WDR41 | WD repeat domain 41 | 2 | 2 | ||||||||
MIRT716734 | APOL6 | apolipoprotein L6 | 2 | 2 | ||||||||
MIRT718781 | RAC3 | Rac family small GTPase 3 | 2 | 2 | ||||||||
MIRT720973 | ZBTB43 | zinc finger and BTB domain containing 43 | 2 | 2 | ||||||||
MIRT720986 | TOM1 | target of myb1 membrane trafficking protein | 2 | 2 | ||||||||
MIRT721391 | LDLRAD4 | low density lipoprotein receptor class A domain containing 4 | 2 | 2 | ||||||||
MIRT722905 | COA4 | cytochrome c oxidase assembly factor 4 homolog | 2 | 2 | ||||||||
MIRT723205 | ZNRF1 | zinc and ring finger 1 | 2 | 2 | ||||||||
MIRT725431 | HIVEP3 | human immunodeficiency virus type I enhancer binding protein 3 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|